Ipratropium Bromide Inhalation Aerosol
Product Images NDC 17270-0401

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide Inhalation (NDC 17270-0401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armstrong Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a description of Ipratropium Bromide HFA Inhalation Aerosol. Each actuation delivers 7 mcg of ipratropium bromide monohydrate from the mouthpiece. The recommended dosage is provided for adults and children. It is essential to follow the dosing instructions for this prescription medication. For more information, including prescribing details and instructions for use, visit amphastar.com or contact Amphastar Pharmaceuticals at 1-800-423-4136.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Figure7 (Figure7)

FDA Label Image

Figure1and2 (Figures1and2)

This description seems to indicate instructions or information related to a medical inhaler or similar device. It may include details about a canister, mouthpiece, dose indicator, and figures displaying dosage levels.*

FDA Label Image

Results (Results)

This text contains information related to drug administration trials comparing different forms and dosages of ipratropium bromide for a certain number of days. The data includes measurements of FEV1 (Forced Expiratory Volume in one second) in Liters at various time points after drug administration. The study compares the effects of Placebo, ipratropium bromide HFA 42 mcg, ipratropium bromide HFA 84 mcg, and ipratropium bromide CFC 42 mcg. The measurements are taken at regular intervals up to at least 8 hours post-administration.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.